The study entitled "Effects of mulberry leaf extract formulationon Postprandial Glycemic Peak in Obese Children and Adolescents: A Pilot Study" aims to evaluate the improvement in glycemic and insulinemic levels produced by a food supplement extracted from white mulberry (Morus alba), after 12 weeks of treatment in a cohort of obese children and adolescents. Clinical and anthropometric data (age, sex, weight, height, BMI, pubertal stage) will be collected, along with data from blood chemistry tests performed during routine follow-up visits, in accordance with Good Clinical Practice guidelines.
Age range
6 Years – 16 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Area Under the Curve for Plasma Glucose
Timeframe: Baseline and Week 12
Area under the curve (AUC) for plasma insulin
Timeframe: Baseline and Week 12
Maximum plasma glucose concentration (Gmax)
Timeframe: Baseline and Week 12
Time to maximum plasma glucose concentration (Tmax)
Timeframe: Baseline and Week 12
Glycated Hemoglobin
Timeframe: Change in glycated hemoglobin from baseline to Week 12, measured in fasting blood samples.
Homeostasis Model Assessment of Insulin Resistance
Timeframe: Baseline to Week 12